Danone's Yogurt Gains FDA Approval for Diabetes Risk Reduction
Danone México has reported a significant development in the dairy sector with the U.S. Food and Drug Administration (FDA) officially recognizing regular yogurt consumption as a means to lower the risk of developing type 2 diabetes. This is particularly relevant in Mexico, where approximately 17% of the population suffers from this metabolic disorder.
Moreover, yogurt presents a viable solution for the 50% of Mexicans who are lactose intolerant. The presence of live microorganisms like Streptococcus thermophilus and Lactobacillus bulgaricus in yogurt aids in the enzymatic breakdown of lactose, making it easier to digest.
Industrial production of yogurt requires stringent quality control, particularly in maintaining the cold chain to preserve the viability of beneficial bacteria. Unlike other fermented products that may lose microbial content due to high temperatures, yogurt must maintain a minimum of 10 million Colony Forming Units (CFUs) per gram, as specified by regulations.
Advancements in food technology have enabled these bacterial strains to withstand gastric acids, and innovative packaging solutions, such as pouch types, allow yogurt to remain fresh for up to six hours without refrigeration.
Mexico is also at the forefront of nutritional personalization, being the third country to join The Human Diets & Microbiome Initiative. This global scientific effort, in collaboration with the University of San Diego and Danone Nutricia Research, aims to map intestinal microbiota across geographical regions by comparing samples with those from the United States, Japan, and the United Kingdom.
The dissemination of scientific knowledge about the gut-brain axis highlights the holistic impact of dairy products, linking dysbiosis to conditions ranging from stress to neurodegenerative diseases. The formal livestock sector agrees that democratizing access to these dairy derivatives is vital for transitioning to an effective preventive health model.
Enhancing efficiency in modern dairy farms to supply genuine high biological value fluids is essential to meet current market biotechnological demands and support the country's food sovereignty.
